Profile: Primus Diagnostics renders accurate & precise analytical systems to the medical community for diagnosing and monitoring patient health through products & services of high standards. We also specialize in products designed to monitor average glucose levels in diabetes. Our PDQ semi automated equipment is designed for the physician's office, clinics and medium size hospital laboratories and Our PDQ Plus, ultra2 A1c is totally automated equipment and methods designed for clinics, medium-size and large hospitals and reference labs.
The company has revenues of USD 10-25 Million, has ~40 employees and is CE certified. NASDAQ:TRIB (SEC Filings)
FDA Registration Number: 3003899053
17 Products/Services (Click for related suppliers)
|
• Blood, Hemoglobin Analyzers |
• Calibrators for Equipment |
• Chemistry Analyzers |
• Clinical Immunochemistry Analyzers |
• General Diagnostic Supplies |
• General Medical Supplies |
• General Surgery Supplies |
• Glycosylated Hemoglobin Assay Test (FDA Code: LCP / 864.7470) A glycosylated hemoglobin assay is a device used to measure the glycosylated hemoglobins (A1a, A1b, and A1c) in a patient's blood by a column chromatographic procedure. Measurement of glycosylated hemoglobin is used to assess the level of control of a patient's diabetes and to determine the proper insulin dosage for a patient. Elevated levels of glycosylated hemoglobin indicate uncontrolled diabetes in a patient. |
• Hemoglobin A1c Analyzers |
• Hemoglobin S (FDA Code: GIQ / 864.7415) An abnormal hemoglobin assay is a device consisting of the reagents, apparatus, instrumentation, and controls necessary to isolate and identify abnormal genetically determined hemoglobin types. |
• Hemoglobin Testing Systems |
• Immuno Chemistry Analyzers |
• Immunoassay Equipment, Immunochemistry Analyzers |
• Laboratory Equipment |
• Laboratory Equipment Devices |
• Scales |
• Sickling Hemoglobin Screening Kit |